The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proton Technologies

26 Sep 2023 07:00

RNS Number : 5869N
Sabien Technology Group PLC
26 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 September 2023

 

Sabien Technology Group plc

("Sabien", the "Company" or the "Group")

 

Proton Technologies

 

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, today announces that it has reviewed the value of its investment in Proton Technologies Canada Inc., ("Proton") following the proposed investment in and restructuring of Proton. 

 

On 14 October 2021, Sabien invested £100,000 in Proton, giving the Company a 0.08% shareholding. Subsequently, Sabien entered into a licensing agreement with Proton on 1 February 2022. This agreement allowed Sabien to deploy Proton's technology within the UK and the right to install a plant for the City Oil Field, Inc. plastic to oil technology on Proton's Saskatchewan site. Sabien retains the rights conferred by this licensing agreement.

 

On 8 September 2023, Proton informed its shareholders that it had received a proposal from a third party to inject new capital, restructure its balance sheet, and reform its management team (the "Proposal"). The Proposal remains subject to shareholder approval.

 

Following a review of the Proposal and ahead of approval by Proton shareholders, the Board of Sabien has concluded that the value of the Company's stake (£100,000) may require a material impairment provision in the accounts for the financial year to 30 June 2023. The Board expects that this provision will allow for a potential material diminution in the value of existing Proton equity to reflect the notional value of Proton ascribed by the Proposal. The level of provision will require agreement with the Company's auditors as part of the current audit process. Details of the provision, if any, will be provided in the Company's final results which are expected to be published in October 2023.

 

Richard Parris, Executive Chairman of Sabien, commented:

 

"While it is disappointing to provide for a possible short-term reduction in Proton's equity value, the Board is encouraged by the constructive details of the Proposal. It is clear that Proton requires a larger capital base from which to develop its leading hydrogen technology and we are supportive of the intention to re-balance the business. It remains to be seen as to the outcome of this Proposal, but Sabien is intent on a prudent approach to its balance sheet and the values contained within it."

 

For Further Information:

 

Sabien Technology Group plc

Richard Parris, Executive Chairman

Scott Fulton, Investor Relations 

 

 

 

+44 20 7993 3700

Scott.fulton@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDCCSDDGXU
Date   Source Headline
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker
15th Mar 20182:42 pmRNSDirector/PDMR Shareholding
28th Feb 20185:34 pmRNSDirector/PDMR Shareholding
28th Feb 20185:32 pmRNSDirector Loan
14th Feb 20182:59 pmRNSResult of General Meeting
5th Feb 20184:22 pmRNSDirector/PDMR Shareholding
31st Jan 201812:33 pmRNSUnaudited Interim Results to 31 December 2017
19th Jan 20185:10 pmRNSNotice of General Meeting
29th Dec 201711:21 amRNSResult of AGM
7th Dec 20173:10 pmRNSNotice of AGM
7th Dec 20177:00 amRNSAudited Annual Report
1st Aug 20177:00 amRNSChange of Adviser
30th Jun 20177:01 amRNSFinance Director Retirement
30th Jun 20177:00 amRNSOrder Received
20th Apr 20174:45 pmRNSHolding(s) in Company
20th Apr 20174:03 pmRNSHolding(s) in Company
20th Apr 201711:15 amRNSHolding(s) in Company
20th Apr 201711:13 amRNSHolding(s) in Company
20th Apr 201711:11 amRNSHolding(s) in Company
18th Apr 20174:56 pmRNSTotal Voting Rights
18th Apr 201711:51 amRNSResult of GM
29th Mar 201710:00 amRNSNotice of GM
29th Mar 20177:30 amRNSResults of Placing
29th Mar 20177:00 amRNSHalf-year Report
30th Dec 201610:05 amRNSHolding(s) in Company
29th Nov 201612:19 pmRNSResult of AGM
29th Nov 201610:41 amRNSAGM Statement
7th Nov 20165:28 pmRNSNotice of AGM
25th Oct 20167:00 amRNSFinal Results
29th Sep 20163:25 pmRNSHolding(s) in Company
22nd Sep 20164:56 pmRNSHolding(s) in Company
22nd Sep 20164:54 pmRNSHolding(s) in Company
22nd Sep 20164:48 pmRNSHolding(s) in Company
16th Sep 20167:00 amRNS£750,000 Placing To Continue Growth Strategy
13th Jul 201610:47 amRNSResult of Meeting
13th Jul 20169:08 amRNSGM Statement
27th Jun 20169:42 amRNSNotice of GM
2nd Jun 20167:00 amRNSTrading Statement
3rd May 20167:00 amRNSUpdate on pilot programme
9th Feb 20167:00 amRNSHalf Yearly Report
6th Jan 20169:44 amRNSChange of name of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.